Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemiaXinyu Li, Yubin Ge, Jun Ma et al.|Haematologica|2019Cited by 68
The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemiaXinyu Li, Yubin Ge, Yongwei Su et al.|Haematologica|2020Cited by 53
Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System TumorsTristan Knight, Gregory A. Yanik, Kwang Woo Ahn et al.|Transplantation and Cellular Therapy|2023Cited by 3
No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastomaTristan Knight, Gregory A. Yanik, Kwang Woo Ahn et al.|Bone Marrow Transplantation|2023Cited by 3